U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07250217) titled 'Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients' on Nov. 14.
Brief Summary: The main objective of this study is to identify epigenetic markers specific to abnormal myeloid cells in patients with acute myeloid leukemia (AML) by analyzing the methylation of circulating cell-free DNA in plasma.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Acute Myeloblastic Leukemia
Intervention:
DIAGNOSTIC_TEST: Epigenetic markers
Methylation profiles will be analyzed and DNA regions (CpG sites) that show significant differences between healthy and pathological cells from bone marrow wil...